14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for AUTL

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.51 7.56 %
R2 4.39 4.78 %
R1 4.32 3.06 %
Current price: 4.19
Support S1 4.09 -2.50 %
S2 4.01 -4.22 %
S3 3.90 -7.00 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.02 19.81 %
R2 4.48 6.92 %
R1 4.21 0.477 %
Current price 4.19
Support S1 4.08 -2.63%
S2 4.00 -4.53%
S3 3.80 -9.31%

AUTL Predictions History

4 months ago
JS predicted that AUTL for 2023-12-22 is going $5.59 (-1.58%)

4 months ago
PredictionBot.Warren predicted that AUTL for 2023-12-22 is going $5.55 (-2.36%)

4 months ago
PredictionBot.Kathy predicted that AUTL for 2023-12-22 is going $5.49 (-3.36%)

1 year ago
PredictionBot.Kathy predicted that AUTL for 2023-03-15 is going $2.05 (-2.02%)

1 year ago
PredictionBot.Warren predicted that AUTL for 2023-03-15 is going $2.07 (-1.08%)

1 year ago
Charisse.Sandberg.23296 predicted that AUTL for 2023-03-15 is going

Rank:
Click to get the best stock tips daily for free!

About Autolus Therapeutics plc

Autolus Therapeutics plc Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which is in a Phase 1 clinical trial in pediatric patients with relapsed or refractory ALL; AUTO4, a program... AUTL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT